NV01-A02

· Neuroventi Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NV01-A02, covering 2025-04-30 to 2025-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder [Phase 2]

See pricing